Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 29 ... and overall survival in patients who were 65 years or older and diagnosed with colon, non-smallcelllung, or breast cancer or diffuse large B-cell lymphoma in 1991-2002. Patients were ...
2009 NOV 23 ... corresponding metastasis has not yet been well documented and analyzed in patients with non-small cell lung cancer (NSCLC)." "The expression of epidermal growth factor receptor (EGFR), ...
2009 NOV 23 ... of human cancer," researchers in the United States report. "In human non-small cell lung cancer, we found that down-regulation was due to epigenetic changes. Consequently, in this ...
2009 NOV 23 ... Fresh data on renal cell carcinoma are presented in the report 'A case of bone, lung, pleural and liver ... events (SREs) such as bone pain caused by bone metastasis from many kinds of cancer." "The patient in the present report had multiple bone metastases from ...
2009 NOV 23 ... in turn, stimulate effector cells such as T cells and NK cells. Lately, CD40-mediated cell growth inhibition and apoptosis have been in focus for the development of novel cancer ... mice 13 d). Furthermore, bladder tumors were eradicated (2 of 10) simultaneously as lung metastases (6 of 10) were cleared. FoxP3 levels were similar in the tumors of ...
2009 NOV 23 ... "To identify the DNA methylation biomarkers for the detection of the stage I non-small cell lung cancer (NSCLC). The methylated state of p16INK4A, ESR1, HOX9, RASSF1A, DAPK1, PTEN, ABCB1, ...
2009 NOV 27 ... that goal for a protein with major roles in cancer, cardiovascular disease and stem cell biology."If human physiology is like a puppet show, then transcription ... Similar abnormalities in NOTCH also underlie a variety of other cancers, including lung, ovarian, pancreatic and gastrointestinal cancers.Even with this deep ...
2009 NOV 23 ... proportional hazards regression model. There were 14 men and six women; 15 cases were non-small cell lung cancer and five cases were small cell lung cancer. The median age was 68 (range, 41-83). The ...
2009 NOV 23 ... have demonstrated differential survival benefit from chemotherapy regimens according to non-small cell lung cancer (NSCLC) histology. We investigated whether the distribution of carcinoma NOS (not ...
2009 NOV 23 ... "In the United States, select EGFRIs have been approved in certain patients with non-small cell lung cancer, metastatic colorectal carcinoma, and advanced squamous cell carcinoma of the head and ...
2009 NOV 23 ... to significantly decrease total number of cells staining positive for the endothelial cell marker CD31 or for the Ki67 marker of cellular proliferation and increase the number of ... (P < 0.05). Importantly, combination treatment was significantly better at reducing lung and lymph node micrometastatic foci when compared to control and individual treatment ... "Paclitaxel is a chemotherapeutic agent used for the treatment of metastatic breast cancer. 2,5,7,8-Tetramethyl-2R-(4R, 8R-12-trimethyltridecyl) chroman-6-yloxyacetic acid (a-TEA) ...
2009 NOV 23 ... and real-time reverse transcription-polymerase chain reaction were used to identify cell sources and expression levels of IL-32. IL-32 expression was lacking in the majority of ... "A strong link has been recently demonstrated between inflammation and lungcancer. Thus, we investigated whether the proinflammatory cytokine IL-32 may be involved ...
2009 NOV 23 ... published in the Journal of Thoracic Oncology, "Skeletal muscle metastases (SMM) from non-small cell lung cancer (NSCLC) are rarely encountered in clinical practice. The prognosis and the adequate ...
2009 NOV 23 ... predisposed to somatic methylation at the MGMT promoter. Peripheral blood monononuclear cell DNA from 89 normal, healthy individuals was genotyped at rs1690625 and assessed for the ... promoter region is a frequent event in several cancer types including colorectal cancer, lungcancer, lymphoma, and glioblastoma. A correlation between methylation and the T allele ...
2009 NOV 23 ... of lungcancer, the prognostic factors for elderly patients with advanced nonsmall-celllungcancer (NSCLC) remain insufficient. Therefore, our aim is to compare the prognostic ...
2009 NOV 23 ... pure ground-glass opacity (GGO) lesions are detected in patients with otherwise operable non-small cell lung cancer, it is controversial whether to resect them simultaneously with the primary tumor or ...
2009 NOV 23 ... from 104 lung resections for lung cancer patients, both men and women, operated on for non-small cell lung cancer, specifically, primary squamous cell carcinoma or adenocarcinoma were studied. Of the ...
2009 NOV 23 ... "Annexin A2 is involved in multiple cellular processes, including cell survival, growth, division, and differentiation. A lack of annexin A2 makes cells more ... around the proliferative but not the necrotic region in BALB/c nude mice with human lung epithelial carcinoma cell A549-derived tumors. Knockdown expression of annexin A2 made ... Keywords: City:Tainan, Country:Taiwan, Apoptosis, Cisplatin, Drugs, Enzymes, Epithelial Cancer, Epithelial Carcinoma, Kinase, Oncology, Pharmaceuticals, Synthase, Therapy, Treatment, ...
